Kyle RA, Rajkumar SV (2006) Monoclonal gammopathy of undetermined significance. Br J Haematol 134:573–589. https://doi.org/10.1111/j.1365-2141.2006.06235.x

Article  PubMed  CAS  Google Scholar 

Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB (2003) Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis 42:87–95. https://doi.org/10.1016/s0272-6386(03)00412-8

Article  PubMed  Google Scholar 

Atkin C, Reddy-Kolanu V, Drayson MT, Sapey E, Richter AG (2020) The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions. Br J Haematol 189:1127–1135. https://doi.org/10.1111/bjh.16487

Article  PubMed  CAS  Google Scholar 

Leung N, Bridoux F, Batuman V et al (2019) The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 15:45–59. https://doi.org/10.1038/s41581-018-0077-4

Article  PubMed  Google Scholar 

Sethi S, Rajkumar SV, D’Agati VD (2018) The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J Am Soc Nephrol 29:1810–1823. https://doi.org/10.1681/ASN.2017121319

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fermand J-P, Bridoux F, Kyle RA et al (2013) International Kidney and Monoclonal Gammopathy Research Group: How I treat monoclonal gammopathy of renal significance (MGRS). Blood 122:3583–3590. https://doi.org/10.1182/blood-2013-05-495929

Article  PubMed  CAS  Google Scholar 

Bridoux F, Leung N, Hutchison CA et al (2015) International Kidney and Monoclonal Gammopathy Research Group: diagnosis of monoclonal gammopathy of renal significance. Kidney Int 87:698–771. https://doi.org/10.1038/ki.2014.408

Article  PubMed  CAS  Google Scholar 

Alfano G, Delrio A, Fontana F et al (2021) Clinical presentation, renal histopathological findings, and outcome in patients with monoclonal gammopathy and kidney disease. Int J Nephrol 2021:8859340. https://doi.org/10.1155/2021/8859340

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kastritis E, Kanellias N, Theodorakakou F et al (2020) Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause. Leuk Lymphoma 61:3247–3250. https://doi.org/10.1080/10428194.2020.1797013

Article  PubMed  Google Scholar 

Yong ZH, Yu XJ, Liu JX, Zhou FD, Wang SX, Zhao MH (2022) Kidney histopathologic spectrum and clinical indicators associated with MGRS. Clin J Am Soc Nephrol 17:527–534. https://doi.org/10.2215/CJN.12890921

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA, Leung N, Cornell LD, Sethi S (2013) C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis 62(3):506–514. https://doi.org/10.1053/j.ajkd.2013.02.370

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schurder J, Rafat C, Vigneron C (2017) Complement-dependent, monoclonal gammapathy-associated thrombotic microangiopathy. Kidney Int 92:516. https://doi.org/10.1016/j.kint.2017.04.039

Article  PubMed  Google Scholar 

Klomjit N, Leung N, Fervenza F, Sethi S, Zand L (2020) Rate and predictors of finding monoclonal gammopathy of renal significance (MGRS) lesions on kidney biopsy in patients with monoclonal gammopathy. J Am Soc Nephrol 31(10):2400–2411. https://doi.org/10.1681/ASN.2020010054

Article  PubMed  PubMed Central  CAS  Google Scholar 

Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB (2003) Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis 42(1):87–95. https://doi.org/10.1016/s0272-6386(03)00412-8

Article  PubMed  Google Scholar 

Du J, Hu Z (2024) Systematic review and meta-analysis of the clinical features of MGRS. BMC Nephrol 25(1):22. https://doi.org/10.1186/s12882-024-03458-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sy-Go JPT, Moubarak S, Vaughan LE, Klomjit N, Viehman JK, Fervenza FC, Zand L (2024) Monoclonal gammopathy and its association with progression to kidney failure and mortality in patients with CKD. Clin J Am Soc Nephrol 19(3):319–328. https://doi.org/10.2215/CJN.0000000000000358

Article  PubMed  Google Scholar 

Fernández de Larrea C, Verga L, Morbini P, Klersy C, Lavatelli F, Foli A, Obici L, Milani P, Capello GL, Paulli M, Palladini G, Merlini G (2015) A practical approach to the diagnosis of systemic amyloidoses. Blood 125(14):2239–2244

Article  PubMed  Google Scholar 

Sigurbergsdóttir AÝ, Love TJ, Kristinsson SY (2022) Autoimmunity, infections, and the risk of monoclonal gammopathy of undetermined significance. Front Immunol 13:876271. https://doi.org/10.3389/fimmu.2022.876271

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hemminki K, Liu X, Försti A, Ji J, Sundquist J, Sundquist K (2012) Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma. J Hematol Oncol 5:59–65. https://doi.org/10.1186/1756-8722-5-59

Article  PubMed  PubMed Central  Google Scholar 

Leeaphorn N, Kue-A-Pai P, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL (2014) Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol 40:29–35. https://doi.org/10.1159/000364782

Article  PubMed  Google Scholar 

Lindqvist EK, Goldin LR, Landgren O et al (2011) Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood 118:6284–6291. https://doi.org/10.1182/blood-2011-04-347559

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brown LM, Gridley G, Check D, Landgren O (2008) Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 111:3388–3394. https://doi.org/10.1182/blood-2007-10-121285

Article  PubMed  PubMed Central  CAS  Google Scholar 

McShane CM, Murray LJ, Landgren O et al (2014) Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review. Cancer Epidemiol Biomarkers Prev 23:332–342. https://doi.org/10.1158/1055-9965

Article  PubMed  CAS  Google Scholar 

Chauvet S, Frémeaux-Bacchi V, Petitprez F et al (2017) Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. Blood 129:1437–1447. https://doi.org/10.1182/blood-2016-08-737163

Article  PubMed  CAS  Google Scholar 

Ravindran A, Go RS, Fervenza FC, Sethi S (2017) Thrombotic microangiopathy associated with monoclonal gammopathy. Kidney Int 91:691–698. https://doi.org/10.1016/j.kint.2016.09.045

Article  PubMed  Google Scholar 

Martins M, Bridoux F, Goujon JM et al (2022) Complement activation and thrombotic microangiopathy associated with monoclonal gammopathy: a national french case series. Am J Kidney Dis 80:341–352. https://doi.org/10.1053/j.ajkd.2021.12.014

Article  PubMed  CAS  Google Scholar 

Dingli D, Larson DR, Plevak MF, Grande JP, Kyle RA (2005) Focal and segmental glomerulosclerosis and plasma cell proliferative disorders. Am J Kidney Dis 46:278–282. https://doi.org/10.1053/j.ajkd.2005.05.004

Article  PubMed  Google Scholar 

Sethi S, Zand L, Leung N, Smith RJH, Jevremonic D, Herrmann SS et al (2010) Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 5:770–782. https://doi.org/10.1038/ki.2014.408